{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:30:48Z","timestamp":1793907048160,"version":"4.8.0"},"reference-count":95,"publisher":"ScopeMed","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.5455\/medarh.2018.72.94-98","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T08:56:16Z","timestamp":1522313776000},"source":"Crossref","is-referenced-by-count":11,"title":["Potential Anti-Inflammatory Treatment of Ischaemic Hearth Disease"],"prefix":"10.5455","member":"3407","reference":[{"key":"ref1","unstructured":"1.  Masic I, Rahimic M, Dilic M, Kadribasic R, Toromanovic S. So -"},{"key":"ref2","unstructured":"cio medical Characteristics of Coronary Diseases in Bosnia and"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Herzegovina. Mater Sociomed. 2011; 23(3): 171-83.","DOI":"10.5455\/msm.2011.23.171-183"},{"key":"ref4","unstructured":"2.  Masic I, Dilic M, Raljevic E, Vulic D, Mott D. Trends in Cardio -"},{"key":"ref5","unstructured":"vascular diseases in Bosnia and Herzegovina and Perspectives"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"with HeartScore Programme. Med Arh. 2010; 64(4): 260-3. Kam","DOI":"10.5455\/medarh.2010.64.260-263"},{"key":"ref7","unstructured":"SW. Persual of risk stratification of acute myocardial infarction"},{"key":"ref8","unstructured":"for half a century, Eur Hear J. 2009; 1030-32.)"},{"key":"ref9","unstructured":"4.  Ford ES, Smith SJ, Strup DF, Steinberg KK, Mueller PW, Thacker"},{"key":"ref10","unstructured":"SB. Homocysteine and cardiovascular disease: a systemic review"},{"key":"ref11","unstructured":"of the evidence with special emphais on case-control studies. Int"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"J epidemiol. 2002; 31(1): 59-70.","DOI":"10.1023\/A:1014857102265"},{"key":"ref13","unstructured":"5.  Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw"},{"key":"ref14","unstructured":"Pepine CJ, Sharaf B, Merz NB, Sopko G, Olson MB, Reis SE. Se -"},{"key":"ref15","unstructured":"rum Amyloid A as a Predictor of Coronary Artery Disease and"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Cardiovascular Outcome in Women, Circulation. 2004; 109: 726-","DOI":"10.1161\/01.CIR.0000127625.99345.73"},{"key":"ref17","unstructured":"6.  Katayama T, Nakashima I, Honda Y, Suzuki S, Yamamoto T, et"},{"key":"ref18","unstructured":"al. Iwasaki Y, Yano L. The Relationship Between Acute Phase Se -"},{"key":"ref19","unstructured":"rum Amyloid A (SAA) Protein Concentrations and Left Ventric-"},{"key":"ref20","unstructured":"ular Systolic Function in Acute Myocardial Infarction Patients"},{"key":"ref21","unstructured":"Treated With Primary Coronary Angioplasty, Int Heart J.\u00a0Janu -"},{"key":"ref22","unstructured":"ary 200; 45-55."},{"key":"ref23","unstructured":"7.  Hodzic E, Perla S, Iglica A, Vucijak M. Seasonal Incidence of Acute"},{"key":"ref24","unstructured":"Coronary Syndrome and its Features. Mater Sociomed. 2018 Mar;"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"30(1): 10-14. doi: 10.5455\/msm.2018.30.10-14.","DOI":"10.5455\/msm.2018.30.10-14"},{"key":"ref26","unstructured":"8.  Ruijter W, Westendorp RGJ, Assendelft WJJ, Eizen WPJ, Craen"},{"key":"ref27","unstructured":"AJM, Cessie S, Gussekloo J. Use of Framingham risk score and"},{"key":"ref28","unstructured":"new biomarkers to predict cardiovascular mortality in older peo -"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"ple: population based observational cohort study. BMJ. 2009; 338:","DOI":"10.1136\/bmj.a3083"},{"key":"ref30","unstructured":"9.  Jha HC, Prasad J, Mittal A. High immunoglobulin A seroposi -"},{"key":"ref31","unstructured":"tivity for combined Chlamydia pneumoniae, Helicobacter pylori"},{"key":"ref32","unstructured":"infection, and high-sensitivity C-reactive protein in coronary ar -"},{"key":"ref33","unstructured":"tery disease patients in India can serve as atherosclerotic marker."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Heart Vessels. 2008; 23(6): 390-6.","DOI":"10.1007\/s00380-008-1062-9"},{"key":"ref35","unstructured":"10.  Reszka E. et al. Detection of infectious agents by polymerase chain"},{"key":"ref36","unstructured":"reaction in human aortic wall. Cardiovascular Pathology. 2008;"},{"key":"ref37","unstructured":"17(5): 297-302.11.  Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR,"},{"key":"ref38","unstructured":"Manninen V, Manttari M, Frick MH, Huttunen JK. Chronic Chla -"},{"key":"ref39","unstructured":"mydia pneumoniae infection as a risk factor for coronary heart"},{"key":"ref40","unstructured":"disease in the Helsinki Heart Study. Ann Intern Med. 1992; 11:"},{"key":"ref41","unstructured":"12.  Jafarzadeh A, Esmaeeli-Nadimi A, Nemati M, Tahmasbi M, Ah-"},{"key":"ref42","unstructured":"madi P. Serum concentrations of Helicobacter pylori IgG and the"},{"key":"ref43","unstructured":"virulence factor CagA in patients with ischaemic heart disease."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"East Mediterr Health J. 2010; 16: 1039-44.","DOI":"10.26719\/2010.16.10.1039"},{"key":"ref45","unstructured":"13.  Cercek B, Shah PK, Noc M, Zahger D, Zeymer U, Matetzky S,"},{"key":"ref46","unstructured":"Maurer G, Mahrer P; AZACS Investigators. Effect of short-term"},{"key":"ref47","unstructured":"therapy wiith azithromycin on recurrent ischaemic events in pa -"},{"key":"ref48","unstructured":"tients with acute coronary syndrome in the Azithromycin in Acute"},{"key":"ref49","unstructured":"Coronary Syndrome (AZACS) trial: a randomised controlled trial."},{"key":"ref50","unstructured":"Lancet. 2003\u00a0Mar 8; 361(9360): 809-13."},{"key":"ref51","unstructured":"14.  Moens AL, Claeys MJ, Wuyts FL, Goovaerts I, Van Hertbruggen"},{"key":"ref52","unstructured":"E, Wendelen LC, Van Hoof VO, Vrints CJ. Effect of folic acid on"},{"key":"ref53","unstructured":"endothelial function following acute myocardial infarction. Am"},{"key":"ref54","unstructured":"J Cardiol. 2007; 99: 476-81."},{"key":"ref55","unstructured":"15.  Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier"},{"key":"ref56","unstructured":"B, Turi ZG, Hess OM. Decreased rate of coronary restenosis af -"},{"key":"ref57","unstructured":"ter  lowering of plasma homocysteine levels. N Engl J Med. 2001;"},{"key":"ref58","unstructured":"345: 1593-1600."},{"key":"ref59","unstructured":"16.  The Heart Outcomes Prevention Evaluation (HOPE) 2 Investi -"},{"key":"ref60","unstructured":"gators. Homocysteine lowering with folic acid and B vitamins in"},{"key":"ref61","unstructured":"vascular disease. N Engl J Med. 2006; 354. Published online be -"},{"key":"ref62","unstructured":"fore print on March 12, 2006 .\/https:\/\/clinicaltrials.gov\/ct2\/show\/"},{"key":"ref63","unstructured":"NCT00106886"},{"key":"ref64","unstructured":"17.  Bonaa KH, Njolstad I, Ueland PM, Schrimer H, Tverdal A, Steigen"},{"key":"ref65","unstructured":"T, Weang H, Nordrehaug JE, Arnesen E, Rasmnussen K;NORVIT"},{"key":"ref66","unstructured":"Trial Investigetors. Homocysteine lowering and cardiovascular"},{"key":"ref67","unstructured":"events after acute myocardial infarction. N Engl J Med. 2006 Apr."},{"key":"ref68","unstructured":"13:354(15):1578-88.Epub 2006\u00a0Mar 12."},{"key":"ref69","unstructured":"18.  MacMahon M, Kirkpatrick C, Cummings CE, Clayton A, Rob -"},{"key":"ref70","unstructured":"inson PJ, Tomiak RH, Liu M, Kush D, Tobert J. A pilot study with"},{"key":"ref71","unstructured":"simvastatin and folic acid\/vitamin B12 in preparation for the Study"},{"key":"ref72","unstructured":"of the Effectiveness of Additional Reductions in Cholesterol and"},{"key":"ref73","unstructured":"Homocysteine (SEARCH). Nutrition, Metabolism, and Cardio -"},{"key":"ref74","unstructured":"vascular Diseases : NMCD [01 Aug 2000; 10(4):195-203."},{"key":"ref75","unstructured":"19.  Hollertz O. Sulphur: the vulnerable factor X in atherosclerosis"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Medical Hypotheses.\u00a0July 2002; 59(1): 35-8.","DOI":"10.1016\/S0306-9877(02)00193-7"},{"key":"ref77","unstructured":"20.  Seneff S, Davidson RM, Lauritzen A, Samsel A, Wainwright G. A"},{"key":"ref78","unstructured":"novel hypothesis for atherosclerosis as a cholesterol sulfate defi -"},{"key":"ref79","unstructured":"ciency syndrome. Theor Biol Med Model. 2015\u00a0May 27; 12:9. doi:"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"10.1186\/s12976-015-0006-1.","DOI":"10.1186\/s12976-015-0006-1"},{"key":"ref81","unstructured":"21.  Li W, Tang C, Jin H, Du J. Regulatory effects of sulfur dioxide"},{"key":"ref82","unstructured":"on the development of atherosclerotic lesions and vascular hy -"},{"key":"ref83","unstructured":"drogen sulfide in atherosclerotic rats. Atherosclerosis. 2011 Apr;"},{"key":"ref84","unstructured":"215(2):323-30."},{"key":"ref85","unstructured":"22.  David N. Juurlink. The cardiovascular safety of azithromy -"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"cin.\u00a0 CMAJ. 2014\u00a0 Oct 21; 186(15): 1127\u20131128. doi:  10.1503\/","DOI":"10.1503\/cmaj.140572"},{"key":"ref87","unstructured":"cmaj.140572.PMCID: PMC4203592."},{"key":"ref88","unstructured":"23.  WA Ray. et al. Azithromycin and the risk of cardiovascular death."},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"N Engl J Med. 2012; 366: 1881,","DOI":"10.1056\/NEJMoa1003833"},{"key":"ref90","unstructured":"24.  Lee RA, Guyton A, Kunz D, Cutter GR, Hoesley CJ. Evaluation of"},{"key":"ref91","unstructured":"baseline corrected QT interval and azithromycin prescriptions in"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"an academic medical center. J Hosp Med. 2016 Jan; 11(1): 15-20.","DOI":"10.1002\/jhm.2448"},{"key":"ref93","unstructured":"25.  Baker WL, Couch KA. Azithromycin for the secondary preven-"},{"key":"ref94","unstructured":"tion of coronary artery disease: a meta-analysis. Am J Health Syst"},{"key":"ref95","unstructured":"Pharm. 2007\u00a0Apr 15; 64(8): 830-6."}],"container-title":["Medical Archives"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/10\/10-1522315720.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:16:27Z","timestamp":1793906187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bibliomed.org\/?mno=295180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":95,"URL":"https:\/\/doi.org\/10.5455\/medarh.2018.72.94-98","relation":{},"ISSN":["0350-199X"],"issn-type":[{"value":"0350-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}